FutureBridge set to engage with industry leaders at 2024 ASCO® Annual Meeting and BIO 2024 International Conference
illi News/10268344

UTRECHT, Netherlands, May 30, 2024 ~ FutureBridge, a leading techno-commercial consulting and advisory company, is gearing up to engage with industry leaders at two highly anticipated conferences. The company's life sciences practice, which provides strategic guidance to global companies in the pharmaceutical, biotech, medtech, diagnostics, and animal health sectors, will be participating in the 2024 ASCO (American Society of Clinical Oncology) Annual Meeting and the BIO International Conference 2024.

According to Shivali Jasrotia, Senior Consultant at FutureBridge, the company is excited to share their expertise on the future of medicines, healthcare solutions, disruptive trends, emerging technologies, and therapeutic platforms at these conferences. They also aim to strengthen relationships with existing clients and establish new collaborations with industry experts from academia, patient advocacy groups, innovators, and key opinion leaders.

The ASCO 2024 Annual Meeting will take place in Chicago from May 31st to June 4th and is expected to attract over 40,000 members. This conference will showcase breakthroughs in oncology including advancements in immune checkpoint blockade optimization, lung cancer treatment, breast cancer diagnostics, early melanoma intervention, and early-stage rectal cancer management. Major pharmaceutical companies will also present outcomes and updates of their clinical programs.

More on illi News
"We will be closely following key clinical trial abstracts presented by companies like AstraZeneca,Janssen,and Bristol Myers Squibb at ASCO 2024. Our team is passionate about these topics and we will be providing a short but insightful analysis for our industry colleagues who are unable to attend this event. We are happy to share this analysis with anyone who requests it," said Jasrotia.

The BIO International Conference 2024 will take place in San Diego from June 3rd to June 6th and is considered the premier biotech networking event with over 20,000 industry leaders expected to attend. This year's participants include top biopharmaceutical companies such as Amgen, Pfizer, Novartis, Merck, and Gilead Sciences. The conference aims to facilitate the discovery of new opportunities and the development of partnerships within the biotech and pharmaceutical sectors.

FutureBridge believes that their expertise in tracking early signals in the industry and their implications sets them apart. They offer solutions for the volatile, uncertain, complex, and ambiguous (VUCA) world through their advisory and consulting services. "We believe that business uncertainties from rising failure risks, declining R&D productivity, high unmet clinical needs, and margin pressures can be overcome with a culture of collective and open innovation. Conferences like ASCO, ESMO, and BIO International bridge gaps in scientific data, uniting the competition, world, and technology for a better future," said Manoj Jiandani, Practice Area Head at FutureBridge.

More on illi News
Jiandani also encourages industry leaders to meet with FutureBridge at ASCO 2024 or BIO International this year to learn how their evidence-based consulting solutions can drive results for pharma leaders and address their most critical business challenges. Interested parties can schedule a meeting or reach out to FutureBridge via email at for more information.

In conclusion, FutureBridge's participation in these conferences highlights their commitment to staying at the forefront of industry developments and providing valuable insights to their clients. With a focus on innovation and collaboration, they aim to help businesses navigate the ever-changing landscape of the life sciences industry.
Filed Under: Business

Show All News | Report Violation


Latest on illi News